Kayentis
Kayentis is a French clinical technology company providing the Clin'form eCOA platform and related services to pharmaceutical, biotechnology, and CRO clients, supporting electronic clinical outcome assessments across 400+ trials in 90+ countries.
- Company typePrivate
- Founded2005
- HeadquartersMeylan, France
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Kayentis does
Kayentis SAS is a privately held French clinical technology company founded in 2005 and headquartered in Meylan, France, with a US regional office in Boston. The company operates as a B2B enterprise solution provider serving pharmaceutical companies, biotechnology firms, and Contract Research Organizations (CROs) conducting clinical trials globally. Its core offering is the Clin'form electronic Clinical Outcome Assessment (eCOA) platform, which captures Patient Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO data across home and on-site settings, supported by modular add-ons including Televisit, Patient Engagement Modules, WebCOA back-up, and external system interoperability with IRT, patient portals, and clinical data lakes.
The platform is extended by a suite of services spanning COA strategy advisory, project management, data management, and worldwide logistics with 24/7 multilingual helpdesk support. In June 2026, Kayentis launched an AI-enabled Interactive eConsent module that uses generative AI and knowledge retrieval to transform lengthy paper consent forms into multimedia guided experiences incorporating video, interactive glossary, and comprehension questions, with 21 CFR Part 11 compliance. The company has supported more than 400 clinical trials across 90+ countries, all clinical phases (I-IV), 20+ therapeutic areas, and over 200 indications.
Kayentis operates an enterprise field sales model with custom quote-based pricing tied to study complexity, geographic scope, and service requirements, typically structured as multi-year subscription contracts. The company reports a 95.9% client recommendation rate and an NPS of +72. Recent strategic actions include a March 2026 strategic alliance with Perceptive eClinical to deliver an integrated eCOA-IRT solution and ongoing product expansion into AI-enabled patient engagement workflows. The company is structured as a Société par Actions Simplifiée (SAS) with share capital of €2,522,119.70 and no identified parent company or external private equity sponsor.
Kayentis firmographics
Firmographics- Name
- Kayentis
- Legal name
- KAYENTIS SAS
- Website
- https://kayentis.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Kayentis is a French clinical technology company providing the Clin'form eCOA platform and related services to pharmaceutical, biotechnology, and CRO clients, supporting electronic clinical outcome assessments across 400+ trials in 90+ countries.
- Ownership category
- akta.pro rank
Kayentis industry classification
Industry- Product category
- Electronic Clinical Outcome Assessment (eCOA) Software
- NAICS
- Computer Systems Design and Related Services (54151), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
- akta.pro primary industry
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
- akta.pro secondary industry
- Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)
Keywords
Where Kayentis is headquartered
LocationHeadquarters
- HQ city
- Meylan
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Kayentis business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- eCOA Platform Licensing and Services: Kayentis provides its Clin'form eCOA platform and related services to pharmaceutical sponsors and CROs conducting clinical trials. The revenue model involves licensing the platform along with comprehensive services including COA strategy advisory, project management, data management, and worldwide logistics support. Services are provided throughout the clinical trial lifecycle from early strategic engagement through database lock.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise custom pricing based on study requirements |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Kayentis product offering
Product offeringCore offering
Kayentis provides the Clin'form electronic Clinical Outcome Assessment (eCOA) platform that captures Patient-Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO questionnaires during clinical trials, either at home or on-site, across all phases (I-IV) and therapeutic areas. The platform is sold with bundled first-class services including COA strategy advisory, project management, data management, worldwide device logistics, and a 24/7 multilingual helpdesk. Modular add-ons extend the platform with embedded Televisit, patient engagement features, external system interoperability (IRT, clinical data lakes, patient portals), an AI-enabled Interactive eConsent solution, and a WebCOA Back-up.
Product overview
Kayentis offers a unified platform-plus-modules architecture centered on the Clin'form eCOA platform — a comprehensive electronic Clinical Outcome Assessment solution that collects PRO, Diary, ObsRO, and ClinRO data at home or on-site. This core platform is extended by modular add-ons including Televisit (embedded telemedicine), Patient Engagement Modules, Connection with External Systems (IRT, patient portal, clinical data lake interoperability), and the newly launched Interactive eConsent Solution (AI-enabled multimedia consent module). The platform is complemented by a suite of first-class services: COA Strategy Advisory Support, Project Management and Governance, Data Management, and Worldwide Logistics with 24/7 Helpdesk. Kayentis supports clinical trials across 20+ therapeutic areas, over 200 indications, and all clinical phases (I–IV) in over 90 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Clin'form: The primary eCOA (Electronic Clinical Outcome Assessment) platform developed by Kayentis for capturing patient data in clinical trials, supporting PRO, Diaries, ObsRO, and ClinRO questionnaires with capabilities for televisit, patient engagement modules, and connection with external systems like IRT.
Products and services
- Clin'form eCOA Platform Kayentis's flagship electronic Clinical Outcome Assessment (eCOA) platform enabling electronic collection of Patient Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO questionnaires at home or on-site, supporting all levels of trial complexity across global clinical studies. Sold to pharmaceutical sponsors, biotechs, and CROs conducting Phase I-IV trials.
- Televisit Module Embedded telemedicine module within the Clin'form eCOA app enabling planned and unplanned televisit sessions between study participants and clinical site personnel, supporting remote consultations during clinical trials.
- Patient Engagement Modules Collection of patient engagement features within Clin'form eCOA designed to ensure high patient compliance, including a patient resources library, Participant Feedback Questionnaire (PFQ), and goal-oriented gamification elements for pediatric populations.
- Connection with External Systems (IRT, Patient Portal, Clinical Data Lake) Interoperability module within Clin'form enabling connection with IRT systems, patient portals, and clinical data lakes, providing a unified access point for patients and sites and streamlining end-to-end clinical data flow.
- Interactive eConsent Solution AI-enabled electronic informed consent module embedded within the Clin'form eCOA platform that transforms complex paper consent forms into simplified, multimedia guided digital experiences with video, interactive glossary, comprehension questions, and 21 CFR Part 11 compliant electronic signatures for on-site, remote, and hybrid consent models.
- WebCOA Back-up Web-based back-up solution for eCOA studies enabling patients to complete questionnaires via any browser when the primary device-based solution is unavailable, ensuring continuous digital data collection without paper reliance.
- COA Strategy Advisory Support Early consulting service provided by Kayentis's scientific and medical experts to help sponsors design a relevant clinical outcome assessment (COA) strategy aligned with regulatory expectations and patient needs.
- Project Management and Governance Dedicated project management services ensuring smooth clinical trial execution and alignment with sponsor standards throughout the study lifecycle.
- Data Management Comprehensive data management services including edit checks, query management, data quality control, audit trails, and robust data analytics to ensure high-quality datasets from the start of each study.
- Worldwide Logistics and 24/7 Helpdesk Global logistics management for device provisioning and a 24/7 multilingual helpdesk providing round-the-clock support to study participants and clinical site staff across all geographies.
Quantifiable outcome
- 89% of sites are very satisfied or satisfied with the Clin'form solution
- +4 more outcomes
Companies that use Kayentis
Customer profileSegments3 records
Ideal customer profiles3 records
Kayentis technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability5 records
Feature7 records
Kayentis partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Perceptive eClinicalcorePerceptive eClinical and Kayentis formed a strategic alliance to deliver a fully integrated eCOA-IRT solution for clinical trials. The partnership addresses industry challenge of digital system fragmentation where sites often use up to 17 different systems in a single study. The combined platform streamlines workflows, improves data quality, and simplifies study setup by combining Perceptive's Interactive Response Technology expertise with Kayentis' eCOA capabilities. Both companies view this as beginning of broader interoperability expansion across the clinical trial lifecycle.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Kayentis competitors and assessment
Company assessmentBroad incumbents
- Medidata Solutions (Dassault Systèmes): Medidata offers the Rave eCOA module as part of its broader EDC/CTMS suite, directly competing with Kayentis's Clin'form in the same pharma/biotech/CRO buyer base. As the market-leading eClinical platform, it sets the benchmark for integrated, end-to-end trial technology that Kayentis must differentiate against.
- Veeva Systems: Veeva's Vault eCOA and Vault Clinical Suite serve the same enterprise pharma customer base as Kayentis, with deep CRM, CTMS, and EDC adjacency. It is a key competitor for full-suite enterprise deals where sponsors prefer a single-vendor stack.
- Oracle Clinical One: Oracle Clinical One (formerly Phase One) provides eCOA alongside EDC, RTSM, and analytics in a unified platform, targeting the same pharma/biotech sponsors. It is one of the most direct platform-suite competitors to Kayentis's specialist eCOA offering.
Direct peers
- Clario: Clario (formed from the merger of ERT and CRF Health) is a direct eCOA specialist competitor with deep therapeutic-area expertise and global trial support, serving the same pharma/CRO customers. It is among the most comparable scale specialists in eCOA.
- Signant Health: Signant Health provides eCOA, eConsent, and rater training solutions for clinical trials, overlapping heavily with Kayentis's product portfolio. It competes for the same CNS, rare disease, and patient-centric trials where Kayentis has stated expertise.
- YPrime: YPrime offers eCOA, IRT, and clinical supply chain solutions for pharma and CROs, with comparable mid-tier positioning to Kayentis. It is a direct competitor for studies requiring integrated eCOA+IRT functionality.
- Medrio: Medrio offers eCOA and eClinical solutions for clinical research, with particular strength in early-phase trials. It competes with Kayentis across phases I–IV and overlaps on therapeutic area breadth and CRO relationships.
Emerging players
- Castor: Castor provides eCOA, EDC, and DCT solutions with a modern, API-first platform targeting the same pharma/biotech segment. It competes with Kayentis for digitally native sponsors and DCT-focused studies, though at a smaller scale.
- ObvioHealth: ObvioHealth is a DCT-native eCOA/virtual trial platform focused on patient-centric trial delivery. It competes with Kayentis in the DCT segment where Kayentis also markets televisit, BYOD, and remote data collection capabilities.
Others
- Perceptive eClinical: Perceptive eClinical is Kayentis's strategic alliance partner for IRT integration, addressing the joint problem of system fragmentation in clinical trials. While not a direct competitor in eCOA, it is a critical ecosystem participant whose relationship direction affects Kayentis's go-to-market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Kayentis social profiles
Digital presenceKayentis compliance and trust
Trust signalCompliance2 records
Kayentis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kayentis leadership team
Management profileNumber of profiles
Profiles6 records
Kayentis funding detail
Funding detailFunding overview
Funding rounds8 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kayentis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kayentis
What does Kayentis do?
Kayentis provides the Clin'form electronic Clinical Outcome Assessment (eCOA) platform that captures Patient-Reported Outcomes (PRO), Diaries, ObsRO, and ClinRO questionnaires during clinical trials, either at home or on-site, across all phases (I-IV) and therapeutic areas. The platform is sold with bundled first-class services including COA strategy advisory, project management, data management, worldwide device logistics, and a 24/7 multilingual helpdesk. Modular add-ons extend the platform with embedded Televisit, patient engagement features, external system interoperability (IRT, clinical data lakes, patient portals), an AI-enabled Interactive eConsent solution, and a WebCOA Back-up.
Is Kayentis a public or private company?
Kayentis is a private company. It is classified as venture growth investor backed and is currently operating.
When was Kayentis founded?
Kayentis was founded in 2005. It employs 101 to 250 people.
Where is Kayentis based?
Kayentis is headquartered in Meylan, France, in the Europe region.
How does Kayentis make money?
One revenue line is on record: eCOA Platform Licensing and Services.
Who are Kayentis's main competitors?
Broad incumbents on record are Medidata Solutions (Dassault Systèmes), Veeva Systems and Oracle Clinical One. Direct peers are Clario, Signant Health, YPrime and Medrio. Emerging players are Castor and ObvioHealth. Perceptive eClinical is listed as an others.
Does Kayentis have an API?
No public API is recorded for Kayentis.
What industry is Kayentis in?
Kayentis's product category is Electronic Clinical Outcome Assessment (eCOA) Software. Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 54151 and its SIC code is 7372.